Saram ConsultingGxP & AI Consulting for Life Sciences. Custom AI integrations, Part 11 compliance validation, and equity-based engineering partnerships for biotech.Explore Services at saram.io →
← Back to Home

Companies in #Non-Muscle Invasive Bladder Cancer

Found 1 company operating in this sector.

CG Oncology is a late-stage clinical biopharmaceutical company developing cretostimogene grenadenorepvec, an investigational oncolytic immunotherapy, for non-muscle invasive bladder cancer. Its Phase 3 program spans BOND-003 in BCG-unresponsive disease and PIVOT-006 as adjuvant monotherapy in intermediate-risk disease following TURBT, with earlier studies exploring high-risk and BCG-naïve populations.

Sector:Oncology / Clinical-Stage Biotech
HQ:Dallas, TX, USA